Pediatric Chronic Disease Specialty Conference Objectives

Friday, April 16, 2010
Pre-conference Symposium: Pediatric Age-based Competencies for Epilepsy
1:00-2:00pm	General Overview of Epilepsy 0180-0000-10-200-L01-P Kim Tallian, PharmD Psychiatry Pharmacist, UCSD Medical Center San Diego, CA At the end of this session, participants will be able to: Review the incidence of epilepsy in children. Review the epilepsy syndromes seen only in children. Discuss the medications of choice in children. Discuss patient specific factors that might make one pick one agent over another. Discuss vigabatrin, refunamide and their place in the treatment of epilepsy.
2:00-3:00pm	Treatment of Status Epilepticus, 0180-0000-10-201-L01-P Elizabeth Farrington, PharmD Clinical Specialist – Pediatrics University of North Carolina Hospitals Durham, NC At the end of this session, participants will be able to: Briefly review standard treatment of status epilepticus Discuss newer treatment options for the treatment of refractory status epilepticus. Review the adverse effects of drug therapies for the treatment of status epilepticus. Understand the monitoring of treatment of refractory status epilepticus.
3:00-3:15pm	Break
3:15-4:15pm	Adverse Effects of Antiepileptic Medications, 0180-0000-10-203-L01-P Stephanie Phelps, PharmD Associate Dean & Professor, The University of Tennessee Memphis, TN At the end of this session, participants will be able to: Review antiepileptic medications that have pharmacogenomic implications. Understand the test used to identify patients with pharmacogenomic alterations. List the common adverse effects with each antiepileptic medication. Discuss adverse skin reactions with antiepileptic medications and implication for future treatment. Understand the anticonvulsant hypersensitivity syndrome. In a patient with a known adverse event, redesign a medication regimen.
4:15-5:15pm	Application of Pharmacogenomics to the treatment of the Patient with Epilepsy, 0180-0000-10-202-L01-P Collin Hovinga, PharmD Assistant Professor, Department of Pharmacy-Pediatrics The University of Tennessee Health Science Center Memphis, TN At the end of this session, participants will be able to: Review the antiepileptic medications that have pharmacogenomic implications. Understand the test used to identify patients with pharmacogenomic alterations. Apply patient specific pharmacogenomic information to make decisions about patient medication therapy.
Pediatric Chronic Diseases Specialty Conference
6:00-7:00pm	Keynote Speaker Dr. Stephen R. Covey 0180-0000-10-204-L04-P Recognized as one of Time magazine's 25 most influential Americans, Stephen R. Covey has dedicated his life to demonstrating how every person can truly control their destiny with profound, yet straightforward guidance. As an internationally respected leadership authority, family expert, teacher, organizational consultant, and author, his advice has given insight to millions. His book The 7 Habits of Highly Effective People was named the #1 Most Influential Business Book of the Twentieth Century.
Saturday, April 17, 2010
7:00-8:00am	Antidepressants and Antipsychotics in Youth: do the Benefits Outweight the Risks?, 0180-0000-10-205-L04-P Julie Dopheide, PharmD, BCPP Associate Professor, University of Southern California School of Pharmacy Los Angeles, CA At the end of this session, participants will be able to: Given a clinical case, recognize appropriate and inappropriate uses of antidepressants and antipsychotics in children and adolescents and recommend optimization of the drug regimen. Recognize and describe antidepressant and antipsychotic side effects that are problematic in youth and recommend monitoring to prevent adverse outcomes. Provide counseling to children, adolescents and their families on the safe and effective use of antidepressants and antipsychotics for managing mood and psychotic disorders.
8:00-9:00am	Patient Assistant Programs 101, 0180-0000-10-206-L04-P Kristin Fox-Smith, BS, MTA Pharmacy Billing Manager, University of Utah Salt Lake City, UT At the end of this session, participants will be able to: Understand enrollment requirements for PAP’s. Understand compliance hurdles to successfully enroll patients in PAP’s. Encourage your facility to take advantage of these programs, and the tools to make this program a success.
9:15-10:15 am	Cultural Diversity and Me, 0180-0000-10-207-L04-P Helen Fiechtner, PharmD, FPPAG Professor, South Dakota State University College of Pharmacy Sioux Falls, SD At the end of this session, participants will be able to: Describe the concepts of cultural diversity and competency. Identify ways to integrate cultural competency into one's professional practice. Discuss how literature can be used to teach cultural diversity/competency.
10:15am-11:15pm	Chronic Dermatology, 0180-0000-10-209-L04-P Kim Benner, PharmD, FASHP Associate Professor of Pharmacy Practice Samford University McWhorter School of Pharmacy, Homewood, AL At the end of this session, participants will be able to: Review the prevalence, etiology and pathophysiology of atopic dermatitis (AD) in pediatrics. Describe the presenting signs and symptoms and related classification of AD. Discuss the importance of non-pharmacologic therapies in AD. Review the available pharmacotherapy, both initial and therapy for refractory cases, to treat AD in the pediatric patient.
12:30-2:00pm	Sickle Cell Workshop, 0180-0000-10-210-L04-P Tracy Hagemann, PharmD Associate Professor, Clinical Pediatric Specialist Director, Pediatric Residency OUHSC-College of Pharmacy Oklahoma City, OK At the end of this session, participants will be able to: Construct a pharmacotherapy plan for health maintenance in a child with sickle cell disease, including appropriate immunizations, antimicrobial and supplement prophylaxis, and pain management. Develop a care plan for a pediatric patient with sickle cell disease that may decrease the frequency of sickle cell crises. Design a treatment plan for iron chelation in a child maintained on chronic transfusion therapy.
12:30-2:00pm	Medication Adherence Workshop, 0180-0000-10-211-L04-P Jim Thigpen, PharmD, BCPS Assistant Professor, Department of Pharmacy Practice Bill Gatton College of Pharmacy Johnson City, TN At the end of this session, participants will be able to: Describe the problems with adherence to medication regimens in the pediatric population. Appraise medicine regimens for likely troubles with adherence. Design a therapeutic plan to optimize adherence in various pediatric patients.
2:15-4:00pm	Residency Project Presentations
4:00-5:30pm	Sickle Cell Workshop, 0180-0000-10-210-L04-P Tracy Hagemann, PharmD Associate Professor, Clinical Pediatric Specialist Director, Pediatric Residency OUHSC-College of Pharmacy Oklahoma City, OK At the end of this session, participants will be able to: Construct a pharmacotherapy plan for health maintenance in a child with sickle cell disease, including appropriate immunizations, antimicrobial and supplement prophylaxis, and pain management. Develop a care plan for a pediatric patient with sickle cell disease that may decrease the frequency of sickle cell crises. Design a treatment plan for iron chelation in a child maintained on chronic transfusion therapy.
4:00-5:30pm	Medication Adherence Workshop, 0180-0000-10-211-L04-P Jim Thigpen, PharmD, BCPS Assistant Professor, Department of Pharmacy Practice, Bill Gatton College of Pharmacy Johnson City, TN At the end of this session, participants will be able to: Describe the problems with adherence to medication regimens in the pediatric population. Appraise medicine regimens for likely troubles with adherence. Design a therapeutic plan to optimize adherence in various pediatric patients.
Sunday, April 18, 2010
8:00-9:00am	Hemophilia Workshop, 0180-0000-10-212-L04-P Hassan Yaish, MD Hemotology Medical Director Primary Children’s Medical Center Salt Lake City, UT At the end of this session, participants will be able to: Describe the most common inherited bleeding disorders, including hemophiliac as well as the more common condition of Von Willebrand’s disease. Discuss the various replacement factor products, the plasma derived and the recombinant, their indication, differences and similarities. Bypassing factors for treatment of patients with inhibitor will also be described. Compared the outcome of treatment in patients on prophylactic protocols and those who are on demand.
9:00-10:30am	Incorporating Pharmaceutical Care into Pediatric HIV, 0180-0000-10-213-L02-P Leslie Briars, PharmD Clinical Assistant Professor Pediatric Ambulatory Care Clinical Pharmacist The University of Illinois at Chicago College of Pharmacy Chicago, IL At the end of this session, participants will be able to: Review highlights of pediatric and adolescent HIV guidelines. Discuss pharmacist’s role in the care of the pediatric HIV patient. Analyze various infant, pediatric and adolescent cases.
9:00-10:30am	Solid Organ Transplant – Long Term Considerations, 0180-0000-10-214-L04-P Sabrina Boehme, PharmD, BCPS Clinical Pediatric Pharmacist Pediatric Transplant Pharmacist Assistant Professor of Pharmacy Practice University of Southern Nevada Primary Children’s Medical Center Henderson, NV At the end of this session, participants will be able to: Review immunosuppressive medications commonly used post transplant. Recognize potential long term complications to be considered in adolescent solid organ transplant patients. Identify potential long term causes of morbidity and mortality post solid organ transplant.
10:30-10:45am	Break
10:45am-12:15pm	Incorporating Pharmaceutical Care into Pediatric HIV, 0180-0000-10-213-L02-P Leslie Briars, PharmD Clinical Assistant Professor, Pediatric Ambulatory Care Clinical Pharmacist The University of Illinois at Chicago College of Pharmacy Chicago, IL At the end of this session, participants will be able to: Review highlights of pediatric and adolescent HIV guidelines. Discuss pharmacist’s role in the care of the pediatric HIV patient. Analyze various infant, pediatric and adolescent cases.
10:45am-12:15pm	Solid Organ Transplant – Long Term Considerations, 0180-0000-10-214-L04-P Sabrina Boehme, PharmD, BCPS Clinical Pediatric Pharmacist Pediatric Transplant Pharmacist Assistant Professor of Pharmacy Practice University of Southern Nevada Primary Children’s Medical Center Henderson, NV At the end of this session, participants will be able to: Review immunosuppressive medications commonly used post transplant. Recognize potential long term complications to be considered in adolescent solid organ transplant patients. Identify potential long term causes of morbidity and mortality post solid organ transplant.
Back to Conference website